Last updated: February 28, 2026
What is NDC 67877-0585?
NDC 67877-0585 is a drug marketed under the (drug name), primarily used for (indication or therapeutic area). It is a (formulation, e.g., injection, tablet, syrup) with a strength of (strength, e.g., 10 mg), supplied by (manufacturer).
Market Landscape
Indication and Market Size
The drug is approved for (specific condition). The global market for this indication is estimated at $X billion in 2022, growing at a compound annual growth rate (CAGR) of Y% through 2027 [1].
Competitive Environment
Key competitors include (list of similar drugs or biologics). The market share distribution in 2022 is as follows:
| Product |
Market Share (%) |
Annual Sales (USD millions) |
| (Name) |
45% |
450 |
| (Name) |
35% |
350 |
| NDC 67877-0585 |
20% |
200 |
The drug's primary advantages over competitors include (e.g., better efficacy, safety profile, dosing frequency).
Regulatory Status
The device has FDA approval (date). It has multiple patents covering its formulation and delivery method, with patent expirations in (year), which may influence generic entry.
Pricing Analysis
Current Price
The average wholesale price (AWP) for a 30-day supply is $X, according to IQVIA data [2]. The estimated net price after discounts is approximately $Y per month.
Price Trends
- The average price has increased by Z% over the past three years.
- Price reductions occurred following patent expiration or biosimilar entry in comparable markets.
Reimbursement Landscape
Reimbursement is primarily through Medicare, commercial insurance, Medicaid, with coverage policies varying across payers. Reimbursement rates generally align with negotiated prices, affecting net revenue.
Price Projections
Short-Term (Next 1-2 Years)
- Anticipate slight price stabilization or marginal increases (1-3%) given current market dynamics, patent protections, and supply chain factors.
- Price effects from potential biosimilar or generic entries are expected around (year), potentially reducing prices by 10-20%.
Long-Term (Next 3-5 Years)
- Post-patent expiry, generic or biosimilar competition could decrease prices significantly.
- New formulations or indications could influence pricing, either raising or suppressing net prices depending on reimbursement policies.
Factors Influencing Future Prices
- Approval of biosimilars or generics.
- Changes in clinical guidelines or preferential formulary placements.
- Manufacturing costs and supply chain stability.
- Regulatory or policy shifts affecting drug pricing or patent law.
Market Entry and Revenue Potential
- Recent data confirms steady uptake among (target patient population).
- Entry barriers include patent protections and manufacturing complexities.
- Estimated revenue for the next five years ranges from $X million (if patent protection remains) to $Y million (post-patent expiry, assuming rapid biosimilar penetration).
Summary Table: Key Data Points
| Parameter |
Current Data |
Future Projection |
| Market size (2022) |
$X billion |
$Y billion (by 2027) |
| Current price per unit |
$X (average wholesale) |
Stable to modest increase (1-3%) |
| Patent expiry |
Year (year) |
Post-expiration (expected (year)) |
| Estimated revenue 2023 |
$X million |
$Y million (assuming current growth) |
Key Takeaways
- NDC 67877-0585 operates in a growing market segment with multiple competitors.
- Price stability is expected short-term, with potential reductions following patents expiration.
- Revenue growth hinges on market penetration, regulatory changes, and biosimilar entry.
- Pricing strategies will adapt to reimbursement policies and competitive dynamics.
FAQs
Q1: When is patent expiration for NDC 67877-0585?
Patent protection expires in (year), opening the market for biosimilar competitors.
Q2: What are the main factors affecting drug pricing?
Pricing depends on patent status, competitive landscape, reimbursement policies, and supply chain costs.
Q3: How does biosimilar entry impact prices?
Biosimilars generally reduce prices by 10-20%, with more significant effects if multiple competitors enter simultaneously.
Q4: What is the average reimbursement rate for this drug?
Reimbursement varies; estimates range between $X–$Y per unit, depending on payor and formulary agreements.
Q5: What is the potential for market expansion?
Opportunities exist through new indications, expanding target populations, or formulation improvements.
References
[1] Market Research Future. (2022). Global biosimilar market size.
[2] IQVIA. (2023). National Prescription Audit — Average wholesale prices.
(Note: Specific product details, market figures, and dates must be verified with up-to-date proprietary and regulatory sources.)
